Skip to main content

Table 3 Coagulation indicators of patients with thrombosis with or without lung cancer

From: Change in cytokine profiles released by mast cells mediated by lung cancer-derived exosome activation may contribute to cancer-associated coagulation disorders

 

LC(n=17)

Non-LC(n=20)

P

PT, s

12.36 ± 1.41

13.91 ± 2.83

0.017

APTT, s

28.21 ± 4.25

37.69 ± 14.11

0.000

TT, s

17.01 ± 1.37

16.87 ± 1.85

0.443

FIB, g/L

  4.03 ± 1.88

  4.45 ± 1.81

0.641

FDP, mg/L

13.22 ± 10.70

31.23 ± 33.72

0.182

D-Dimer, mg/L

    6.8 ± 7.18

  9.31 ± 10.99

0.537

AT-III, %

91.32 ± 10.33

87.93 ± 12.1

0.519

  1. All data were present as mean ± standard deviation. Mann–Whitney test was used to compare the differences
  2. Abbreviations: LC Lung cancer, PT Prothrombin time, TT Thrombin time, APTT Activated partial thromboplastin time, FIB Fibrinogen, FDP Fibrin/fibrinogen degradation products, AT-III Antithrombin III
Back to article page

Cell Communication and Signaling

ISSN: 1478-811X